Colesevelam Oral Suspension as Monotherapy or Add-on to Metformin Therapy in Pediatric Subjects With Type 2 Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 31 Aug 2017
At a glance
- Drugs Colesevelam (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms WELKid DM
- Sponsors Daiichi Sankyo Inc
- 10 Jun 2017 Biomarkers information updated
- 31 May 2017 Planned End Date changed from 1 Nov 2016 to 1 Jun 2019.
- 31 May 2017 Planned primary completion date changed from 1 Nov 2016 to 1 Jun 2019.